Kyung Su Kim1,2, Ah Ram Chang3, Kyubo Kim2, Hyeon Kang Koh4, Won Il Jang5, Hae Jin Park6, Ji Hyun Chang7, Mi-Sook Kim4. 1. Department of Radiation Oncology, Dongnam Institute of Radiological and Medical Sciences, Busan, Republic of Korea. 2. Department of Radiation Oncology, Ewha Womans University College of Medicine, Seoul, Republic of Korea. 3. Department of Radiation Oncology, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Republic of Korea. 4. Department of Radiation Oncology, Konkuk University School of Medicine, Seoul, Republic of Korea. 5. Department of Radiation Oncology, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea. 6. Department of Radiation Oncology, Hanyang University College of Medicine, Seoul, Republic of Korea. 7. Department of Radiation Oncology, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Republic of Korea.
Abstract
OBJECTIVE: To evaluate the results of post-operative radiation therapy (RT) for anal squamous cell carcinoma (ASCC) incidentally detected after excision, and compare these outcomes with those of definitive RT without excision for exploring the possibility of treatment de-intensification. METHODS AND MATERIALS: A total of 25 patients with T1-2N0-1 ASCC who underwent RT following incidental tumor resection were selected from multicenter retrospective database. And, we selected one-to-one matched 25 patients receiving definitive RT from the same database using propensity score matching method, and the outcomes were compared. RESULTS: Median age was 60 years (range, 30-76), and 18 patients (72%) were female. 19 patients (76%) had T0/1 tumors and four patients (16%) had regional lymph node metastases. Hemorrhoidectomy was performed in eight patients (32%) and the others underwent local excision. 12 patients (48%) had microscopic or gross residual diseases. Median RT dose to the primary lesion was 50.4 Gy (range, 40-60). Concurrent chemotherapy was delivered to 23 patients (92%). Median follow-up period was 71 months (range, 4.5-203.1 months). None of the patients showed recurrence during follow-up. However, one patient died after 6 months due to the chemotherapy-related hematologic toxicity. When compared with those patients receiving definitive RT, clinicopathological variables were well-balanced between the two groups. While matched paired patients treated with definitive RT received a higher median RT dose of 54 Gy (range, 45-61.2) and concurrent chemotherapy was given to 22 patients (88%), overall survival was not significantly different (p = 0.262). CONCLUSION: Patients treated with RT for early stage ASCC after local excision showed favorable treatment outcomes. Further study is warranted to justify the de-intensification of the treatment for these patients. ADVANCES IN KNOWLEDGE: Post-operative RT can achieve favorable treatment outcomes in incidental ASCC with residual diseases after local excision.
OBJECTIVE: To evaluate the results of post-operative radiation therapy (RT) for anal squamous cell carcinoma (ASCC) incidentally detected after excision, and compare these outcomes with those of definitive RT without excision for exploring the possibility of treatment de-intensification. METHODS AND MATERIALS: A total of 25 patients with T1-2N0-1 ASCC who underwent RT following incidental tumor resection were selected from multicenter retrospective database. And, we selected one-to-one matched 25 patients receiving definitive RT from the same database using propensity score matching method, and the outcomes were compared. RESULTS: Median age was 60 years (range, 30-76), and 18 patients (72%) were female. 19 patients (76%) had T0/1 tumors and four patients (16%) had regional lymph node metastases. Hemorrhoidectomy was performed in eight patients (32%) and the others underwent local excision. 12 patients (48%) had microscopic or gross residual diseases. Median RT dose to the primary lesion was 50.4 Gy (range, 40-60). Concurrent chemotherapy was delivered to 23 patients (92%). Median follow-up period was 71 months (range, 4.5-203.1 months). None of the patients showed recurrence during follow-up. However, one patient died after 6 months due to the chemotherapy-related hematologic toxicity. When compared with those patients receiving definitive RT, clinicopathological variables were well-balanced between the two groups. While matched paired patients treated with definitive RT received a higher median RT dose of 54 Gy (range, 45-61.2) and concurrent chemotherapy was given to 22 patients (88%), overall survival was not significantly different (p = 0.262). CONCLUSION: Patients treated with RT for early stage ASCC after local excision showed favorable treatment outcomes. Further study is warranted to justify the de-intensification of the treatment for these patients. ADVANCES IN KNOWLEDGE: Post-operative RT can achieve favorable treatment outcomes in incidental ASCC with residual diseases after local excision.
Authors: J P Gerard; O Chapet; F Samiei; E Morignat; S Isaac; C Paulin; P Romestaing; V Favrel; F Mornex; J Y Bobin Journal: Cancer Date: 2001-07-01 Impact factor: 6.860
Authors: Stephen R Thompson; Isabel S Y Lee; Susan Carroll; Sarah Bishop; Philip Douglas; Francis Lam; Chris Brown; Janet Williams; David Goldstein Journal: ANZ J Surg Date: 2018-03-07 Impact factor: 1.872
Authors: M Flam; M John; T F Pajak; N Petrelli; R Myerson; S Doggett; J Quivey; M Rotman; H Kerman; L Coia; K Murray Journal: J Clin Oncol Date: 1996-09 Impact factor: 44.544
Authors: E Touboul; M Schlienger; L Buffat; D Lefkopoulos; F Pène; R Parc; E Tiret; D Gallot; M Malafosse; A Laugier Journal: Cancer Date: 1994-03-15 Impact factor: 6.860
Authors: Franz Rödel; Ulrike Wieland; Ingeborg Fraunholz; Julia Kitz; Margret Rave-Fränk; Hendrik A Wolff; Christian Weiss; Ralph Wirtz; Panagiotis Balermpas; Emmanouil Fokas; Claus Rödel Journal: Int J Cancer Date: 2014-05-27 Impact factor: 7.396
Authors: Sakti Chakrabarti; Zhaohui Jin; Brandon M Huffman; Siddhartha Yadav; Rondell P Graham; Dora M Lam-Himlin; Amy L Lightner; Christopher L Hallemeier; Amit Mahipal Journal: J Gastrointest Oncol Date: 2019-04